Cushing’s Treatment Approved

The FDA has approved mifepristone (Korlym, Corcept Therapeutics) for controlling hyperglycemia in adults with endogenous Cushing’s syndrome. The drug was approved for use in patients who also have type 2 diabetes or glucose intolerance and in whom surgery is either contraindicated or has proven unsuccessful. Source:...